TrialInvestigational new drugs2021

Durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis following concurrent chemoradiotherapy: a multicenter prospective cohort study.

Takeya Sugimoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.